SHARIAH / WAM In a high-level meeting chaired by Sheikha Bodour Al Qasimi, the Board ...
Read More »Samsung’s bio-drug unit to raise $2bn in upcoming IPO
Seoul / AFP Samsung’s drug-manufacturing unit plans to raise as much as $2.0 billion in November with what looks set to be South Korea’s third-largest initial public offering (IPO). Samsung Biologics, a contract manufacturer of biotech drugs for global pharmaceutical firms, had announced the IPO plan back in April — with parent Samsung Group seeking new growth engines as ...
Read More »